Cytosorbents CTSO
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q2 | 7.48 | 74.33 | -1.4 | -2,638 | -4 | |
| 2026Q1 | 11.33 | 71.25 | -1.6 | -3,044 | -5 | |
| 2025Q4 | 12.78 | 92.3 | -1.8 | -4,385 | -5 | |
| 2025Q3 | 18.68 | 97.81 | -1 | -2,862 | -3 | |
| 2025Q2 | 25.6 | -140.95 | 0.6 | -3,614 | 2 | |
| 2025Q1 | 20 | 445.25 | -0.4 | -3,887 | -1 | |
| 2024Q4 | 18.2 | 43.19 | -2.8 | -3,729 | -8 | |
| 2024Q3 | 30 | 242.17 | -1 | -4,514 | -2 | |
| 2024Q2 | 14.06 | 87.15 | -1.6 | -3,688 | -4 | |
| 2024Q1 | 19 | 77.55 | -2.2 | -4,926 | -6 | |
| 2023Q4 | 22.2 | 141.62 | -2.6 | -9,341 | -6 | |
| 2023Q3 | 37.6 | 80.97 | -4.2 | -7,417 | -9 | |
| 2023Q2 | 71.8 | 106.75 | -2.8 | -6,559 | -6 | |
| 2023Q1 | 67.4 | 108.66 | -3.4 | -7,892 | -7 | |
| 2022Q4 | 31 | 332.43 | -0.2 | -6,356 | -1 | |
| 2022Q3 | 27.2 | 73.63 | -5.6 | -9,017 | -12 | |
| 2022Q2 | 43.8 | 76.65 | -5 | -8,357 | -11 | |
| 2022Q1 | 63.8 | 86.82 | -4.2 | -7,791 | -9 | |
| 2021Q4 | 83.8 | 95.1 | -4.4 | -9,562 | -9 | |
| 2021Q3 | 162.4 | 84.22 | -3 | -5,406 | -6 |